Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer

Clinical trial NCT00058539 · COMPLETED

Trial details

NCT number: NCT00058539
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2003-04-01
Primary completion: 2004-10-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.